Bringing home the point that the venture cycle is maturing with later-stage deals sucking up more and more capital, London- and Geneva-based Index Ventures is launching a $577 million (400 million Euro) growth fund. It will invest in later-stage deals requiring $30 to $70 million each, and will focus mostly on European companies, including biotech.
This is a departure for Index, whose current fund (index Ventures IV) has done extremely well investing in seed and early-stage deals, including Skype, MySQL, and Last.fm. The new fund, which is called Index Ventures Growth I, will be managed by Index co-founder Giuseppe Zocco; Dominique Vidal, previously CEO of Yahoo! Europe and co-founder of Kelkoo; and Guido Magni, formerly the Global Head of Medical Science, Pharmaceutical Division, F. Hoffman-La Roche Ltd. Basel, Switzerland.
first…
Eric – is it for early or late stage ?
Mashable are reporting conflicting view – they are saying “seed and early-stage” investments ?
http://mashable...dex-ventures-2/
?
Tchruncher2, it’s for late stage and not for seed. There is a mistake in the mashable article. It’s not possible to have early stage funds between €20 million and €50 million as indicated on the Mashable Article.
I wish them luck. They’re great guys at Index – down to earth, smart and always helping out in the local startup scene here in Geneva.
Just want to clarify that this fund, the Index Growth Fund, has been raised with the purpose of investing in late(r) stage companies – not seed or early stage investments. We will of course continue to invest in early stage companies, as we’ve always done, but those investments will come out of the Index IV fund which was raised last year.
Good news for growth Companies.
http://tekno-wo...ld.blogspot.com
Any idea what the total fund Index has under management?